Details of the Drug Reposition

General Information of This Drug (ID: DM0C1IX)

Drug Name
Anti-MUC1 CAR T Cells   DM0C1IX
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Pancreatic cancer DISJC981 2C10 Phase 1/2 [1]
Hepatocellular carcinoma DIS0J828 2C12.02 Phase 1/2 [1]
Breast cancer DIS7DPX1 2C60-2C65 Phase 1/2 [1]
Non-small-cell lung cancer DIS5Y6R9 2C25.Y Phase 1/2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02587689) Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor
2 ClinicalTrials.gov (NCT03525782) Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC